CD70 and cancer: CD70 has been postulated as a putative pan-cancer target for immunotherapy, which is supported by bulk RNA-seq data from the TCGA PCAWG Firehose cohort demonstrating varying CD70 mRNA expression levels across 28 different cancer types (Fig. 1A).